Nasdaq
RDHL
Redhill Biopharma Ltd.
- Health Care
- Israel
- 1 day
- −13.3%
- 1 month
- −21.0%
- 1 year
- −52.8%
$0.5810 · Mkt cap $3.53M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Redhill Biopharma Ltd.
$0.5810 · Mkt cap $3.53M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Redhill Biopharma Ltd. trades under the ticker RDHL on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $3.53M. The last closing price was $0.5810, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −52.8%, and −21.0% over the past month. Returns are price returns and exclude dividends.
This page exists because RDHL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.